Liposome composition for delivery of therapeutic agents
    6.
    发明申请
    Liposome composition for delivery of therapeutic agents 审中-公开
    用于递送治疗剂的脂质体组合物

    公开(公告)号:US20050191344A1

    公开(公告)日:2005-09-01

    申请号:US11036523

    申请日:2005-01-13

    摘要: A neutral cationic lipid and liposomes prepared from the neutral cationic lipid are described. Liposomes comprised of the lipid are suitable for delivery of a polyanionic compound, such as a nucleic acid. The delivery can be performed in vivo or ex vivo. The neutral cationic lipid, which is neutral in charge at physiologic pH and positively charged at pH values less than physiologic pH, contains a polar head group that imparts solubility of the lipid and permits its packing into a liposomal lipid bilayer.

    摘要翻译: 描述了由中性阳离子脂质制备的中性阳离子脂质和脂质体。 由脂质组成的脂质体适合于递送聚阴离子化合物,例如核酸。 递送可以在体内或体外进行。 中性阳离子脂质在生理pH值为中性,pH值小于生理pH值时带正电,含有极性头基团,赋予脂质溶解性并允许其包入脂质体脂质双层。

    Releasable linkage and compositions containing same
    7.
    发明授权
    Releasable linkage and compositions containing same 有权
    可释放的连接物和含有它们的组合物

    公开(公告)号:US07592307B2

    公开(公告)日:2009-09-22

    申请号:US11810931

    申请日:2007-06-06

    摘要: A conjugate comprised of a hydrophilic polymer covalently yet reversibly linked to a amine-, hydroxy- or carboxyl-containing ligand is described. The resulting conjugate is capable of releasing the parent amine, hydroxy, or carboxyl-containing compound via thiol-mediated cleavage. The system allows for delivery of various amino-, hydroxy-, or carboxy-containing drugs in the form of their thiolytically cleavable macromolecular conjugates.

    摘要翻译: 描述了由共价但可逆地连接到含胺,羟基或羧基的配体的亲水性聚合物组成的缀合物。 所得的缀合物能够通过硫醇介导的切割释放母体胺,羟基或含羧基的化合物。 该系统允许以其可硫裂解的大分子缀合物的形式递送各种氨基,羟基或羧基的药物。

    Method for treating multi-drug resistant tumors
    8.
    发明授权
    Method for treating multi-drug resistant tumors 有权
    多药耐药肿瘤治疗方法

    公开(公告)号:US07303760B2

    公开(公告)日:2007-12-04

    申请号:US10714085

    申请日:2003-11-14

    摘要: Methods for administering mitomycin C to a multi-drug resistant cell and for reducing the toxicity of the compound are described. In the methods, mitoymic C is provided in the form of a prodrug conjugate, where the drug is linked to a hydrophobic moiety, such as a lipid, through a cleavable dithiobenzyl linkage. The dithiobenzyl linkage is susceptible to cleavage by mild thiolysis, resulting in release of mitomycin C in its original form. The linkage is stable under nonreducing conditions. The prodrug conjugate can be incorporated into liposomes for administration in vivo and release of mitomycin C in response to endogenous in vivo reducing conditions or in response to administration of an exogenous reducing agent.

    摘要翻译: 描述了向多药耐药细胞施用丝裂霉素C并降低化合物的毒性的方法。 在该方法中,丝裂蛋白C以前体药物缀合物的形式提供,其中药物通过可裂解的二硫代苄基键连接到疏水部分,例如脂质。 二硫代苄基键易受到轻度硫解的裂解,导致丝裂霉素C以其原始形式释放。 在非还原条件下,连接是稳定的。 可以将前体药物缀合物掺入用于体内施用的体内脂质体中,并响应内源性体内还原条件或响应外源性还原剂的施用而释放丝裂霉素C.